Previous Nav
Net Change on 31-03-2023
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
Sun Pharmaceutical Industries Ltd.
Max Healthcare Institute Ltd.
Cipla Ltd.
Aether Industries Ltd.
Global Health Ltd.
Rainbow Children's Medicare Ltd.
Apollo Hospitals Enterprise Ltd.
Abbott India Ltd.
Medplus Health Services Ltd.
Krishna Institute Of Medical Sciences Ltd.
Alkem Laboratories Ltd.
Narayana Hrudayalaya Ltd.
JB Chemicals & Pharmaceuticals Ltd.
Fortis Healthcare Ltd.
Torrent Pharmaceuticals Ltd.
Lupin Ltd.
Divi's Laboratories Ltd.
Zydus Lifesciences Ltd.
Gland Pharma Ltd.
Ami Organics Ltd.
Gufic Biosciences Ltd.
TREPS
Shreno Ltd.
Net Receivable / Payable
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Chemicals
Miscellaneous
Cash
Equity
Preference Shares
SBI Healthcare Opportunities Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to SBI Mutual Fund. It was launched on 01-Jan-2013 and currently has an AUM of ₹1,574.52 crore. SBI Healthcare Opportunities Fund is benchmarked against S&P BSE Health Care - TRI as primary index and S&P BSE SENSEX - TRI as secondary index.
The NAV of SBI Healthcare Opportunities Fund ended up ₹1.39(0.57%)yesterday to ₹242.7219.
Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and
The SBI Healthcare Opportunities Fund is managed by Tanmaya Desai .
191, Maker Tower 'E' Cuffe Parade Mumbai - 400 005